PROCTER & GAMBLE HEALTH | UNICHEM LAB | PROCTER & GAMBLE HEALTH/ UNICHEM LAB |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.5 | 236.1 | 14.6% | View Chart |
P/BV | x | 10.5 | 1.4 | 740.8% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH UNICHEM LAB |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
UNICHEM LAB Mar-23 |
PROCTER & GAMBLE HEALTH/ UNICHEM LAB |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 467 | 1,149.0% | |
Low | Rs | 3,883 | 226 | 1,718.1% | |
Sales per share (Unadj.) | Rs | 740.7 | 190.7 | 388.3% | |
Earnings per share (Unadj.) | Rs | 138.2 | -28.7 | -481.3% | |
Cash flow per share (Unadj.) | Rs | 155.2 | -12.6 | -1,230.5% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 344.2 | 130.1% | |
Shares outstanding (eoy) | m | 16.60 | 70.41 | 23.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.8 | 343.7% | |
Avg P/E ratio | x | 33.5 | -12.1 | -277.3% | |
P/CF ratio (eoy) | x | 29.8 | -27.5 | -108.5% | |
Price / Book Value ratio | x | 10.3 | 1.0 | 1,026.1% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 24,396 | 314.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 3,564 | 57.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 13,430 | 91.6% | |
Other income | Rs m | 184 | 385 | 47.7% | |
Total revenues | Rs m | 12,480 | 13,815 | 90.3% | |
Gross profit | Rs m | 3,247 | -841 | -386.0% | |
Depreciation | Rs m | 281 | 1,134 | 24.8% | |
Interest | Rs m | 8 | 173 | 4.4% | |
Profit before tax | Rs m | 3,142 | -1,764 | -178.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 259 | 327.6% | |
Profit after tax | Rs m | 2,295 | -2,022 | -113.5% | |
Gross profit margin | % | 26.4 | -6.3 | -421.6% | |
Effective tax rate | % | 27.0 | -14.7 | -183.9% | |
Net profit margin | % | 18.7 | -15.1 | -123.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 15,885 | 73.7% | |
Current liabilities | Rs m | 6,791 | 6,396 | 106.2% | |
Net working cap to sales | % | 40.0 | 70.7 | 56.7% | |
Current ratio | x | 1.7 | 2.5 | 69.4% | |
Inventory Days | Days | 263 | 51 | 513.0% | |
Debtors Days | Days | 343 | 1,600 | 21.5% | |
Net fixed assets | Rs m | 10,617 | 15,911 | 66.7% | |
Share capital | Rs m | 166 | 141 | 117.9% | |
"Free" reserves | Rs m | 7,265 | 24,092 | 30.2% | |
Net worth | Rs m | 7,431 | 24,233 | 30.7% | |
Long term debt | Rs m | 0 | 636 | 0.0% | |
Total assets | Rs m | 22,330 | 31,829 | 70.2% | |
Interest coverage | x | 409.1 | -9.2 | -4,452.6% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.4 | 130.5% | |
Return on assets | % | 10.3 | -5.8 | -177.5% | |
Return on equity | % | 30.9 | -8.3 | -370.1% | |
Return on capital | % | 42.4 | -6.4 | -662.8% | |
Exports to sales | % | 0 | 69.7 | 0.0% | |
Imports to sales | % | 13.1 | 12.4 | 105.1% | |
Exports (fob) | Rs m | NA | 9,366 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 1,669 | 96.2% | |
Fx inflow | Rs m | 1,465 | 9,366 | 15.6% | |
Fx outflow | Rs m | 1,605 | 1,669 | 96.2% | |
Net fx | Rs m | -140 | 7,697 | -1.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -851 | -277.4% | |
From Investments | Rs m | -215 | 2,028 | -10.6% | |
From Financial Activity | Rs m | -985 | -813 | 121.1% | |
Net Cashflow | Rs m | 1,160 | 746 | 155.6% |
Indian Promoters | % | 0.0 | 70.2 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.3 | 11.3 | 179.1% | |
FIIs | % | 7.6 | 0.8 | 904.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 29.8 | 161.8% | |
Shareholders | 56,730 | 20,877 | 271.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Unichem Lab | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.55% | 1.90% | 1.18% |
1-Month | -7.47% | -5.40% | -0.75% |
1-Year | -3.02% | 78.12% | 61.82% |
3-Year CAGR | -9.12% | 16.06% | 18.16% |
5-Year CAGR | 5.75% | 19.87% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Unichem Lab share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Unichem Lab the stake stands at 70.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Unichem Lab.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Unichem Lab paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Unichem Lab.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.